HCA HEALTHCARE INC
HCANYSE🏆 #136 by market capEarnings Jan 25 · PostUS Equity
$463.22▲ $13.27 (+2.95%)
🌙 After hours$462.10▼ 0.24%Regular close · extended-hours price shownTrack HCA
Get earnings, price moves & breaking news on Telegram
24h▲ 3.0%
7d▲ 0.9%
14d▼ 1.5%
30d▲ 7.0%
ytd▼ 0.7%
1y▼ 0.7%
🏦Market Cap
$100.29B
Mid Cap
📈Revenue Growth (YoY)
7.3%
Slowing
📊Gross Margin
85.3%
High
💵FCF Margin
7.7%
Moderate
⚖️P/S Ratio
1.3x
Cheap
Otter Score
88
Excellent
HCA HEALTHCARE INC
HCAAnalyst Ratings
Price
$463.22
Total
46
Raised
2
Lowered
7
Avg PT
$462.29
H / L
$579 / $369
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Keybanc | Reiterated | Overweight | 2026-10-28 | $490.00 | +5.80% |
TD Cowen | Reiterated | Buy | 2026-10-28 | — | — |
Baird | Reiterated | Neutral | 2026-10-28 | — | — |
B of A Securities | Reiterated | Neutral | 2026-10-28 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-07 | $496.00 | +7.10% |
Leerink Partners | Reiterated | Outperform | 2026-09-18 | $286.00 | −38.30% |
JP Morgan | Reiterated | Neutral | 2026-08-20 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2026-08-03 | $369.00 | −20.30% |
Goldman Sachs | Reiterated | Buy | 2026-07-28 | $485.00 | +4.70% |
Mizuho | Reiterated | Outperform | 2026-07-28 | — | — |
Morgan Stanley | Reiterated | Underweight | 2026-07-27 | $380.00 | −18.00% |
UBS | Reiterated | Buy | 2026-07-27 | $579.00 | +25.00% |
Barclays | Reiterated | Equal Weight | 2026-07-27 | $387.00 | −16.50% |
Oppenheimer | Reiterated | Outperform | 2026-07-27 | $485.00 | +4.70% |
Truist Securities | Reiterated | Buy | 2026-07-27 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-07-07 | $525.00 | +13.30% |
Bernstein | Reiterated | Market Perform | 2026-06-04 | $413.00 | −10.80% |
Stephens & Co. | Reiterated | Overweight | 2026-04-27 | — | — |
Argus Research | Reiterated | Buy | 2026-02-06 | — | — |
Deutsche Bank | Reiterated | Buy | 2026-01-28 | $476.00 | +2.80% |
Jefferies | Reiterated | Buy | 2026-01-28 | $450.00 | −2.90% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2025-07-28 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2024-11-22 | $528.00 | +14.00% |
Citigroup | Reiterated | Buy | 2023-10-25 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-07-28 | $250.00 | −46.00% |
Loop Capital | Reiterated | Buy | 2023-04-24 | — | — |
Cowen & Co. | Reiterated | Outperform | 2023-01-30 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-12-16 | — | — |
BMO Capital | Downgraded | Market Perform → Underperform | 2022-07-06 | $495.00 | +6.90% |
Seaport Global | Reiterated | Buy | 2021-07-09 | — | — |
Piper Sandler | Reiterated | Neutral | 2020-11-25 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-22 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2019-12-06 | — | — |
Argus | Reiterated | Buy | 2018-11-06 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-09-04 | — | — |
PiperJaffray | Downgraded | Overweight → Neutral | 2018-01-03 | — | — |
William Blair | Reiterated | Market Perform → Perform | 2017-11-21 | — | — |
Avondale Partners | Downgraded | Market Outperform → Market Perform | 2016-11-09 | — | — |
KeyBanc | Upgraded | Hold → Overweight | 2016-10-13 | $490.00 | +5.80% |
Evercore ISI Group | Reiterated | Hold | 2016-09-23 | — | — |
Longbow Research | Downgraded | Outperform → Market Perform | 2016-01-06 | — | — |
Wedbush | Reiterated | Outperform | 2015-06-10 | — | — |
Sterne Agee | Reiterated | Buy | 2014-12-18 | — | — |
Monness Crespi Hardt | Reiterated | Buy | 2014-03-31 | — | — |
Macquarie | Downgraded | Outperform → Neutral | 2013-03-12 | — | — |
Imperial Capital | Reiterated | Outperform | 2013-01-17 | — | — |
Institution
Keybanc
Reiterated · Overweight · 2026-10-28
$490.00
+5.80%
TD Cowen
Reiterated · Buy · 2026-10-28
—
—
Baird
Reiterated · Neutral · 2026-10-28
—
—
B of A Securities
Reiterated · Neutral · 2026-10-28
—
—
RBC Capital
Reiterated · Outperform · 2026-10-07
$496.00
+7.10%
Leerink Partners
Reiterated · Outperform · 2026-09-18
$286.00
−38.30%
JP Morgan
Reiterated · Neutral · 2026-08-20
—
—
Wells Fargo
Reiterated · Equal Weight · 2026-08-03
$369.00
−20.30%
Goldman Sachs
Reiterated · Buy · 2026-07-28
$485.00
+4.70%
Mizuho
Reiterated · Outperform · 2026-07-28
—
—
Morgan Stanley
Reiterated · Underweight · 2026-07-27
$380.00
−18.00%
UBS
Reiterated · Buy · 2026-07-27
$579.00
+25.00%
Barclays
Reiterated · Equal Weight · 2026-07-27
$387.00
−16.50%
Oppenheimer
Reiterated · Outperform · 2026-07-27
$485.00
+4.70%
Truist Securities
Reiterated · Buy · 2026-07-27
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-07-07
$525.00
+13.30%
Bernstein
Reiterated · Market Perform · 2026-06-04
$413.00
−10.80%
Stephens & Co.
Reiterated · Overweight · 2026-04-27
—
—
Argus Research
Reiterated · Buy · 2026-02-06
—
—
Deutsche Bank
Reiterated · Buy · 2026-01-28
$476.00
+2.80%
Jefferies
Reiterated · Buy · 2026-01-28
$450.00
−2.90%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2025-07-28
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2024-11-22
$528.00
+14.00%
Citigroup
Reiterated · Buy · 2023-10-25
—
—
Credit Suisse
Reiterated · Outperform · 2023-07-28
$250.00
−46.00%
Loop Capital
Reiterated · Buy · 2023-04-24
—
—
Cowen & Co.
Reiterated · Outperform · 2023-01-30
—
—
SVB Leerink
Reiterated · Outperform · 2022-12-16
—
—
BMO Capital
Downgraded · Market Perform → Underperform · 2022-07-06
$495.00
+6.90%
Seaport Global
Reiterated · Buy · 2021-07-09
—
—
Piper Sandler
Reiterated · Neutral · 2020-11-25
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-04-22
—
—
Bank of America
Upgraded · Neutral → Buy · 2019-12-06
—
—
Argus
Reiterated · Buy · 2018-11-06
—
—
Leerink Swann
Reiterated · Outperform · 2018-09-04
—
—
PiperJaffray
Downgraded · Overweight → Neutral · 2018-01-03
—
—
William Blair
Reiterated · Market Perform → Perform · 2017-11-21
—
—
Avondale Partners
Downgraded · Market Outperform → Market Perform · 2016-11-09
—
—
KeyBanc
Upgraded · Hold → Overweight · 2016-10-13
$490.00
+5.80%
Evercore ISI Group
Reiterated · Hold · 2016-09-23
—
—
Longbow Research
Downgraded · Outperform → Market Perform · 2016-01-06
—
—
Wedbush
Reiterated · Outperform · 2015-06-10
—
—
Sterne Agee
Reiterated · Buy · 2014-12-18
—
—
Monness Crespi Hardt
Reiterated · Buy · 2014-03-31
—
—
Macquarie
Downgraded · Outperform → Neutral · 2013-03-12
—
—
Imperial Capital
Reiterated · Outperform · 2013-01-17
—
—
One row per institution · price target from the firm's latest published target